Analysts Set Option Care Health, Inc. (NASDAQ:OPCH) PT at $35.75

Option Care Health, Inc. (NASDAQ:OPCH) has earned an average recommendation of “Moderate Buy” from the nine analysts that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $35.75.

OPCH has been the topic of several recent analyst reports. Barrington Research reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a research report on Tuesday, September 23rd. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research report on Thursday, July 31st. Finally, JMP Securities increased their price objective on Option Care Health from $36.00 to $38.00 and gave the company a “market outperform” rating in a research report on Thursday, July 31st.

Option Care Health Trading Up 0.9%

NASDAQ OPCH opened at $27.54 on Thursday. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. Option Care Health has a 12 month low of $21.39 and a 12 month high of $35.53. The stock has a market cap of $4.47 billion, a P/E ratio of 22.03, a P/E/G ratio of 1.66 and a beta of 0.83. The stock’s fifty day moving average price is $28.54 and its 200-day moving average price is $30.97.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.35 billion. During the same period last year, the firm posted $0.30 earnings per share. Option Care Health’s revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, equities analysts forecast that Option Care Health will post 1.22 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Norman L. Wright bought 3,411 shares of the company’s stock in a transaction on Tuesday, September 9th. The shares were acquired at an average cost of $29.31 per share, with a total value of $99,976.41. Following the completion of the transaction, the director owned 15,501 shares of the company’s stock, valued at approximately $454,334.31. This trade represents a 28.21% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Timothy P. Sullivan bought 20,000 shares of the company’s stock in a transaction on Thursday, August 21st. The stock was purchased at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the transaction, the director directly owned 49,229 shares of the company’s stock, valued at approximately $1,354,289.79. The trade was a 68.43% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 59,411 shares of company stock valued at $1,627,576. Insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Durable Capital Partners LP raised its stake in shares of Option Care Health by 134.2% in the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after buying an additional 4,720,988 shares during the period. Fuller & Thaler Asset Management Inc. raised its stake in shares of Option Care Health by 30.8% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company’s stock worth $146,947,000 after buying an additional 989,048 shares during the period. Arrowstreet Capital Limited Partnership raised its stake in shares of Option Care Health by 109.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock worth $110,770,000 after buying an additional 1,778,279 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Option Care Health by 4.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company’s stock valued at $91,209,000 after purchasing an additional 99,574 shares during the period. Finally, Norges Bank bought a new stake in Option Care Health during the 2nd quarter valued at approximately $69,932,000. Institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.